BackTable Tumor BoardShareCase · 28 Oct 2025HNC: T2N3 Primary Low Volume Head & Neck Squamous Cell Carcinomawith Dr. Dylan Roden, Dr. Ravindra Uppaluri, Dr. Adam LuginbuhlHead and Neck Cancer (HNC)Head and Neck OncologyImmunotherapyNeoadjuvant ImmunotherapyOncologyOtolaryngologyPathologyResectionSurgical OncologyYou may also likeLoadingLoadingLoadingLoading
